Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 223

    1.

    Long-term low-dose maintenance pegylated interferon may prevent decompensation in cirrhotic patients with portal hypertension: are we there yet?

    D'Amico G, Tine F.

    Hepatology. 2012 Feb;55(2):642-5. doi: 10.1002/hep.24695. No abstract available.

    PMID:
    22287292
    [PubMed]
    2.

    Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.

    Huang HC, Wang SS, Hsin IF, Chang CC, Lee FY, Lin HC, Chuang CL, Lee JY, Hsieh HG, Lee SD.

    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25625. [Epub ahead of print]

    PMID:
    22290687
    [PubMed - as supplied by publisher]
    3.

    Liver stiffness predicts clinical outcome in HIV/HCV-coinfected patients with compensated liver cirrhosis.

    Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Márquez-Solero M, Omar M, Macías J, Camacho A, Pérez-Pérez M, Gómez-Mateos J, Rivero A, Pineda JA; on behalf of the Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25616. [Epub ahead of print]

    PMID:
    22278746
    [PubMed - as supplied by publisher]
    4.

    Frequent detection of IgM anti-herpes simplex viral antibody in patients with primary biliary cirrhosis.

    Fujiwara K, Yokosuka O.

    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25597. [Epub ahead of print] No abstract available.

    PMID:
    22271592
    [PubMed - as supplied by publisher]
    5.

    A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients.

    D'Ambrosio R, Aghemo A, Grazia Rumi M, Ronchi G, Donato MF, Paradis V, Colombo M, Bedossa P.

    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25606. [Epub ahead of print]

    PMID:
    22271347
    [PubMed - as supplied by publisher]
    6.

    Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.

    Corpechot C, Carrat F, Poujol-Robert A, Gaouar F, Wendum D, Chazouillères O, Poupon R.

    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25599. [Epub ahead of print]

    PMID:
    22271046
    [PubMed - as supplied by publisher]
    7.

    Informed consent in surveillance for hepatocellular carcinoma in patients with cirrhosis.

    Rowe IA, Armstrong MJ, Parker R, Houlihan DD.

    Hepatology. 2012 Jun;55(6):2039. doi: 10.1002/hep.25588. No abstract available.

    PMID:
    22262284
    [PubMed - in process]
    8.

    Cognitive dysfunction in cirrhosis is associated with falls: A prospective study.

    Soriano G, Román E, Córdoba J, Torrens M, Poca M, Torras X, Villanueva C, Gich IJ, Vargas V, Guarner C.

    Hepatology. 2012 Jun;55(6):1922-30. doi: 10.1002/hep.25554. Epub 2012 Apr 4.

    PMID:
    22213000
    [PubMed - in process]
    9.

    Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database.

    Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF.

    Hepatology. 2012 May;55(5):1398-405. doi: 10.1002/hep.25544. Epub 2012 Mar 18.

    PMID:
    22213344
    [PubMed - in process]
    10.

    Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.

    Yang YY, Tsai TH, Huang YT, Lee TY, Chan CC, Lee KC, Lin HC.

    Hepatology. 2012 May;55(5):1540-50. doi: 10.1002/hep.25534. Epub 2012 Apr 4.

    PMID:
    22183953
    [PubMed - in process]
    11.

    Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

    Fernández J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, Seva-Pereira T, Corradi F, Mensa J, Ginès P, Arroyo V.

    Hepatology. 2012 May;55(5):1551-61. doi: 10.1002/hep.25532. Epub 2012 Apr 4.

    PMID:
    22183941
    [PubMed - in process]
    12.

    PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.

    Trepo E, Guyot E, Ganne-Carrie N, Degre D, Gustot T, Franchimont D, Sutton A, Nahon P, Moreno C.

    Hepatology. 2012 Apr;55(4):1307-8. doi: 10.1002/hep.25518. No abstract available.

    PMID:
    22162034
    [PubMed - indexed for MEDLINE]
    13.

    Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities.

    Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, Fontaine H, Roulot D, Mallat A, Hillaire S, Cales P, Ollivier I, Vinel JP, Mathurin P, Bronowicki JP, Vilgrain V, N'Kontchou G, Beaugrand M, Chevret S; Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH).

    Hepatology. 2011 Dec;54(6):1987-97. doi: 10.1002/hep.24545.

    PMID:
    22144108
    [PubMed - indexed for MEDLINE]
    14.

    The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.

    Liu L, Yannam GR, Nishikawa T, Yamamoto T, Basma H, Ito R, Nagaya M, Dutta-Moscato J, Stolz DB, Duan F, Kaestner KH, Vodovotz Y, Soto-Gutierrez A, Fox IJ.

    Hepatology. 2012 May;55(5):1529-39. doi: 10.1002/hep.24815. Epub 2012 Apr 4.

    PMID:
    22109844
    [PubMed - in process]
    15.

    Quantitative histological-hemodynamic correlations in cirrhosis.

    Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G.

    Hepatology. 2012 Apr;55(4):1146-53. doi: 10.1002/hep.24805.

    PMID:
    22109744
    [PubMed - indexed for MEDLINE]
    16.

    Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology.

    Molho-Pessach V, Rios JJ, Xing C, Setchell KD, Cohen JC, Hobbs HH.

    Hepatology. 2012 Apr;55(4):1139-45. doi: 10.1002/hep.24781. Epub 2012 Feb 8.

    PMID:
    22095780
    [PubMed - indexed for MEDLINE]
    17.

    To feed or what to feed in cirrhosis?

    Johnston R, Dolman G, Aithal G.

    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24771. [Epub ahead of print] No abstract available.

    PMID:
    22095649
    [PubMed - as supplied by publisher]
    18.

    Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense.

    Teltschik Z, Wiest R, Beisner J, Nuding S, Hofmann C, Schoelmerich J, Bevins CL, Stange EF, Wehkamp J.

    Hepatology. 2012 Apr;55(4):1154-63. doi: 10.1002/hep.24789. Epub 2012 Feb 15.

    PMID:
    22095436
    [PubMed - indexed for MEDLINE]
    19.

    Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.

    Ghany MG, Kim HY, Stoddard A, Wright EC, Seeff LB, Lok AS; HALT-C Trial Group.

    Hepatology. 2011 Nov;54(5):1527-37. doi: 10.1002/hep.24550.

    PMID:
    22045670
    [PubMed - indexed for MEDLINE]
    20.

    Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care.

    Innes HA, Hutchinson SJ, Allen S, Bhattacharyya D, Bramley P, Delahooke TE, Dillon JF, Forrest E, Fraser A, Gillespie R, Goldberg DJ, Kennedy N, McDonald S, McLeod A, Mills PR, Morris J, Hayes P; Hepatitis C Clinical Database Monitoring Committee.

    Hepatology. 2011 Nov;54(5):1547-58. doi: 10.1002/hep.24561. Erratum in: Hepatology. 2011 Dec;54(6)2280-2.

    PMID:
    22045672
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk